BIOLOGICAL · Unmapped registry intervention
High Dose Trivalent Influenza Vaccine
Find medicine records ·
Find other trials using this name
Clinical trial
INfluenza Vaccine to Effectively Stop Cardio Thoracic Events and Decompensated Heart Failure
NCT02787044
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
BIOLOGICAL · Unmapped registry intervention
Standard Dose Quadrivalent Influenza Vaccine
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedINfluenza Vaccine to Effectively Stop Cardio Thoracic Events and Decompensated Heart Failure
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE4
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Heart Failureverified · MONDO: heart failure
Interventions
Sponsors & collaborators
Brigham and Women's Hospitallead sponsor
University of Wisconsin, Madisoncollaborator
University of Torontocollaborator
Boston VA Research Institute, Inc.collaborator
Patient-Centered Outcomes Research Institutecollaborator
University of Minnesotacollaborator
Mapped research locations
TorontoOntario, Canada6MontrealQuebec, Canada5New YorkNew York, United States4BostonMassachusetts, United States3ChicagoIllinois, United States3St LouisMissouri, United States3NashvilleTennessee, United States3MinneapolisMinnesota, United States3MilwaukeeWisconsin, United States3VancouverBritish Columbia, Canada3MadisonWisconsin, United States3OttawaOntario, Canada3
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02787044 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.